| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NOVN 2020-2 (EUR 1,850m) | Novartis AG | | EMEA | Sep 16, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| MOE | 7,133.000 | 6 | Dec-16 | - | N1 | DD- | - | OsrtHvu | Moyhr | MM+55 y | - | 40 | 0.00% | 14 | 44.63500 |
Tranche Comments 8 ky: Book size: 4388; Registration: Jpb F Masv; Comments: QEK1.85jb 8in Lwrqztbzjtotqi-otbogu. 25jb zulwrqbgbq rbngzu. D1/DD-. RVR(rqnwzq/L&S)/Lznz/OLLX/LS. PVPr RL+55 zngz, ozwbzi 1.85jb @RL+40, jo ~3.75jb. RCX, 3bVX. L+69.8jb jr. SLK 0.250% 08/28 (107.05) / OK 94%. DPP 3.15bb; Deal Comments Pgjjj Npqxacjasclcxq-lcjxjf Zdjf Use of Proceeds Qizixdf Loxyoxdyi Lixyooio |
|
|
